NasdaqCM - Nasdaq Real Time Price • USD
Orgenesis Inc. (ORGS)
As of 11:39 AM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -0.16 | -0.17 | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 165k | 12M | 530k | 70.3M |
| Low Estimate | 19.2M | 12M | 50.3M | 70.3M |
| High Estimate | 19.2M | 12M | 50.3M | 70.3M |
| Year Ago Sales | 13.62M | 7.04M | 36.02M | 530k |
| Sales Growth (year/est) | -98.80% | 70.40% | -98.50% | 13,164.20% |
Earnings History
| CURRENCY IN USD | 12/31/2022 | 3/31/2023 | 6/30/2023 | 9/30/2023 |
|---|---|---|---|---|
| EPS Est. | 0 | 0.05 | 0.06 | 0.1 |
| EPS Actual | -0.16 | -0.17 | -0.15 | -0.43 |
| Difference | -0.16 | -0.22 | -0.21 | -0.53 |
| Surprise % | -- | -440.00% | -350.00% | -530.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0.18 | 0.04 | 0.21 | 0.61 |
| 30 Days Ago | 0.18 | 0.04 | 0.21 | 0.61 |
| 60 Days Ago | 0.18 | 0.04 | 0.21 | 0.61 |
| 90 Days Ago | 0.18 | 0.04 | 0.21 | 0.61 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | ORGS | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 1.50% |
| Next Qtr. | -- | -- | -- | 11.40% |
| Current Year | -- | -- | -- | 5.20% |
| Next Year | -- | -- | -- | 13.40% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | Benchmark: Speculative Buy to Speculative Buy | 6/14/2023 |
| Reiterates | Benchmark: Buy | 3/22/2023 |
| Initiated | Benchmark: Speculative Buy | 9/26/2019 |
Related Tickers
CLGN CollPlant Biotechnologies Ltd.
5.36
-0.92%
PYPD PolyPid Ltd.
4.5571
+0.82%
CAMX.ST Camurus AB (publ)
476.60
-0.54%
QNRX Quoin Pharmaceuticals, Ltd.
0.6200
-3.50%
MNPR Monopar Therapeutics Inc.
0.6210
-5.40%
HSTC HST Global, Inc.
0.9400
+44.62%
SLRX Salarius Pharmaceuticals, Inc.
0.4780
-5.91%
APTCF Advanced Proteome Therapeutics Corporation
0.0002
0.00%
ALZN Alzamend Neuro, Inc.
0.7000
-1.30%
SIGY Sigyn Therapeutics, Inc.
5.75
0.00%